Structure and development of a clinical decision support system: application in high Digestive Gastroenterology
Clinical decision requires to infer great, diverse and not suitably organized quantity of information and having low time to decide. The therapeutic choice is fundamental to formulate a strategy to avoid complications and to achieve favorable results, being more important in some specialties. In addition, medical decision-mak ers are overloaded with clinical tasks, have an intense work rate and are subject to a great demand, and are prone to greater tiredness.
1.1. Introduction: Medical education worldwide is undergoing a pedagogical renovation movement; medical simulation is one of the revolutionary educational tools whose aim is to improve the medical knowledge, technical and non-technical skills of health professionals, while ensuring patient safety. Many studies have dealt with the contribution of simulation in cardiology, however no studies have been done on the management of cardiovascular emergencies in pregnant women by simulation.
Cardiac myxomas are the most common primary cardiac tumor. Clinical findings are numerous and range from general manifesta tions to symptoms related to intra-cardiac obstruction or systemic embolization. Echocardiography is the key exam for the diagnosis and surgery allows tumor resection and the prevention of compli cations.
Throughout the COVID-19 Pandemic, the symptoms of loss of smell and taste have been commonly encountered by healthcare professionals, and in fact, have become an important screening tool. By some estimates, 96% of COVID-19 patients experience these symptoms to various degrees . While the exact mecha nism of cellular events that lead to loss of smell and taste is large ly unknown, research is underway to better understand the pro cess. The senses are usually regained with time but often can take months, and in some instances, be permanent . Nearly one out of ten patients have not fully recovered by two months and treat ment options so far are limited . The use of a low dose of Gab apentin could be a possible treatment for anosmia and ageusia in COVID-19 patients.